MACROGENICS INC Logo

MACROGENICS INC

A biopharmaceutical company developing antibody-based therapeutics for cancer.

MGNX | US

Overview

Corporate Details

ISIN(s):
US5560991094
LEI:
Country:
United States of America
Address:
9704 MEDICAL CENTER DRIVE, 20850 Rockville

Description

MacroGenics, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative antibody-based therapeutics for the treatment of cancer. The company utilizes its proprietary antibody engineering platforms, including the DART (Dual-Affinity Re-Targeting) and TRIDENT technologies, to create novel product candidates. Its pipeline consists of investigational treatments such as monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific antibodies. MacroGenics maintains fully-integrated capabilities, from research and discovery through to GMP (Good Manufacturing Practice) manufacturing, to advance its portfolio of potential medicines for patients with unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-10 22:07
FORM 4
English 6.9 KB
2025-11-20 22:01
8-K
English 55.9 KB
2025-11-12 22:04
8-K
English 264.8 KB
2025-11-12 22:04
10-Q
English 1.1 MB
2025-11-12 21:27 English 8.0 KB
2025-08-21 22:19
FORM 4
English 7.2 KB
2025-08-19 22:15
FORM 4
English 6.9 KB
2025-08-19 22:12
FORM 4
English 6.9 KB
2025-08-15 23:05
FORM 4
English 7.4 KB
2025-08-15 23:01
FORM 4
English 6.9 KB
2025-08-15 03:24 English 9.9 KB
2025-08-14 22:09
S-8
English 74.1 KB
2025-08-14 22:06
10-Q
English 1.2 MB
2025-08-14 22:04
8-K
English 263.9 KB
2025-08-14 19:02 English 11.7 KB

Automate Your Workflow. Get a real-time feed of all MACROGENICS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MACROGENICS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MACROGENICS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Cessatech A/S Logo
A biotech company developing medicines for children's acute pain management.
Denmark
CESSA
CG Invites Co., Ltd. Logo
A biopharmaceutical company specializing in digital genomics and personalized medicine.
South Korea
083790
CG Oncology, Inc. Logo
Develops bladder-sparing oncolytic immunotherapies for urologic cancers.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapeutics using proprietary adjuvant platforms.
South Korea
261780
Develops and manufactures veterinary medicines and functional feed additives.
South Korea
052670
Chemical Works of Gedeon Richter Plc Logo
Vertically integrated pharma company focused on women's health and other therapies.
Hungary
RICHT
Chemomab Therapeutics Ltd. Logo
Clinical-stage biotech developing therapeutics for fibro-inflammatory diseases.
United States of America
CMMB
CHINA PHARMA HOLDINGS, INC. Logo
Develops, manufactures, and markets prescription, OTC, and nutritional products.
United States of America
CPHI
China SXT Pharmaceuticals, Inc. Logo
Researches, develops, manufactures, and sells traditional Chinese medicine products.
United States of America
SXTC
ChoA Pharmaceutical Co., LTD. Logo
Develops, manufactures, and sells pharmaceutical products and health supplements.
South Korea
034940

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.